Development of slow release reagent of NFkB decoy oligodeoxynucleotides for the treatment of rheumatic arthritis

治疗风湿性关节炎的NFkB诱饵寡脱氧核苷酸缓释试剂的研制

基本信息

  • 批准号:
    13558109
  • 负责人:
  • 金额:
    $ 8.13万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

We attempted to prolong release of NFkB oligodeoxynudeotid.es without degradation. First, we tested the efficiency of introduction of FITC-labeled oligonucleotides into cultured cells using atelocollagen. No fluorescence was detected at 48 hours after the transfer to HeLa, BHK-21 and human tongue cancer cell line SAS. Then, we developed HVJ (hemagglutinating virus of Japan ; Sendai virus) envelope vector which can introduce synthetic oligonucleotides, proteins, peptides and chemical drugs as well as genes. FITC-labeled oligonucleotides were incorporated into HVJ envelope vector by the treatment of mild detergent and centrifugation. Ten minutes after incubation of those cultured cells described above with the HVJ envelope vector, fluorescence was observed in almost all the nuclei of the cells. When NFkB decoy oligonucleotides were introduced into cancer cells such as SAS and HeLa cells using HVJ envelope vector, apoptosis after irradiation was enhanced by the suppression of NFkB-induced … More gene expression. When FITC-labeled NFkB decoy oligonucleotides were introduced into the joint space of Cynomolgus monkeys using HVJ envelope vector, fluorescence was detected at both synovium and articular cartilage. Next, HVJ envelope vector was embedded with various polymers. First, without polymer, HVJ envelope vector reaches spleen by intravenous injection and FITC-oligonucleotides were detected at the marginal zone of mouse spleen. Then, the vector containing luciferase gene was decorated with protamine suifate and the complex was injected into tail vein of mouse. Gene expression was detected exclusively in lung, not in spleen. Furthermore, when HVJ envelope vector mixed with heparin was injected into muscle or brain directly, gene expression was approximately 5 fold increased than that without heparin. The effect of polymers on slow release of the vector is being investigated, but we have got preliminary data suggesting that cationic polymers may enhance slow release of HVJ envelope vector. Less
我们试图延长NFKB寡头氧化物nudeotid.es的释放而不会降解。首先,我们使用atelocollagen测试了将FITC标记的寡核苷酸引入培养细胞中的效率。转移到HELA,BHK-21和人舌癌细胞系SAS后48小时未检测到荧光。然后,我们开发了HVJ(日本的血凝病毒;仙台病毒)包膜载体,该载体可以引入合成寡核苷酸,蛋白质,胡椒粉和化学药物以及基因。通过处理轻度探测器和离心机,将FITC标记的寡核苷酸掺入HVJ包膜载体中。在与HVJ包膜载体描述的那些培养的细胞孵育十分钟后,几乎所有细胞的核都观察到荧光。当NFKB诱饵寡核苷酸使用HVJ包膜载体引入癌细胞,例如SAS和HeLa细胞时,通过抑制NFKB诱导的……更多的基因表达来增强照射后的凋亡。当使用HVJ包膜载体将FITC标记的NFKB诱饵寡核苷酸引入cynomolgus猴子的关节空间时,在滑膜和关节软骨处都检测到荧光。接下来,将HVJ信封矢量嵌入各种聚合物。首先,没有聚合物,HVJ包膜矢量通过静脉注射到达脾脏,并在小鼠臂的边缘区域检测到FITC-寡核苷酸。然后,含有荧光素酶基因的载体装饰有蛋白质,并将复合物注入小鼠的尾静脉中。在肺中仅检测到基因表达,而不是在SLEEN中。此外,当将HVJ包膜矢量与肝素混合直接注入肌肉或大脑时,基因表达大约比没有肝素的hvj载体增加了约5倍。正在研究聚合物对向量缓慢释放的影响,但是我们有初步数据表明阳离子聚合物可能会增强HVJ包膜载体的缓慢释放。较少的

项目成果

期刊论文数量(40)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kaneda, Y.: "Pharmaceutical Gene Delivery Systems"Alain Rolland and Sean Sullivan(in press). (2003)
Kaneda, Y.:“药物基因传递系统”Alain Rolland 和 Sean Sullivan(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Taniyama, Y., Tachibana, K., Hiraoka, K., Nainba, T., Yamasaki, K., Hashiya, N., Aoki, M., Ogihara, T., Kaneda, Y., and Morishita, R.: "Local delivery of plasmid DNA into rat carotid artery using ultrasound"Circulation. 105. 1233-1239 (2002)
Taniyama, Y.、Tachibana, K.、Hiraoka, K.、Nainba, T.、Yamasaki, K.、Hashiya, N.、Aoki, M.、Ogihara, T.、Kaneda, Y. 和 Morishita, R.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kaneda, Y., Nakajima, T., Nishikawa, T., Yamamoto, S., Ikegami, H., Suzuki, N., Nakamura, H., Morishita, R, and Kotani, H: "HVJ (hemagglutinating virus of Japan) envelope vector as a versatile gene delivery system"Molecular Therapy. 6. 219-226 (2002)
Kaneda, Y.、Nakajima, T.、Nishikawa, T.、Yamamoto, S.、Ikegami, H.、Suzuki, N.、Nakamura, H.、Morishita, R 和 Kotani, H:“HVJ(血凝病毒
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Endoh, M., Koibuchi, N., Sato, M., Morishita, R., Kanzaki, T., Murata, Y. and Kaneda, Y: "Fetal gene transfer by intra-uterine injection with microbubble-enhanced ultrasound"Molecular Therapy. 5. 501-505 (2002)
Endoh, M.、Koibuchi, N.、Sato, M.、Morishita, R.、Kanzaki, T.、Murata, Y. 和 Kaneda, Y:“通过微泡增强超声子宫内注射进行胎儿基因转移”分子
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ueno, T., et al., Kaneda, Y., Matsuda, H.: "Nuclear factor-kB decoy attenuates neuronal damage after global brain ischemia ; a future strategy for brain protection during circulatory arrest"Cardiopulomonary Support and Physiology. 122. 720-727 (2001)
Ueno, T., et al., Kaneda, Y., Matsuda, H.:“核因子-kB 诱饵可减轻全脑缺血后的神经元损伤;循环停止期间脑保护的未来策略”心肺支持和生理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANEDA Yasufumi其他文献

KANEDA Yasufumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANEDA Yasufumi', 18)}}的其他基金

Molecular mechanism of cancer cell pluripotency responding to stress
癌细胞多能性响应应激的分子机制
  • 批准号:
    24659149
  • 财政年份:
    2012
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of multi-lateral cancer gene therapy by enhancing anti-tumor activity of inactivated Sendai virus particle
通过增强灭活仙台病毒颗粒的抗肿瘤活性开发多方癌症基因疗法
  • 批准号:
    22300339
  • 财政年份:
    2010
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Transcriptional regulation of osteogenesis using siRNA and its application to bone formation
siRNA对成骨的转录调控及其在骨形成中的应用
  • 批准号:
    17300153
  • 财政年份:
    2005
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of anti-cancer strategy to increase sensitivity of cancer cells to chemotherapy using siRNA combined with HVJ-E vector
利用siRNA联合HVJ-E载体开发提高癌细胞对化疗敏感性的抗癌策略
  • 批准号:
    15300163
  • 财政年份:
    2003
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic study of correction of mutated gene in xeroderma pigmentosum group A
着色性干皮病A组突变基因纠正的基础研究
  • 批准号:
    10470505
  • 财政年份:
    1998
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Isolation and characterization of tumor-specific antigen toward cancer gene therapy
用于癌症基因治疗的肿瘤特异性抗原的分离和表征
  • 批准号:
    09044306
  • 财政年份:
    1997
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Development of new DDS to individual organs by means of cell technology and its opplication to treatment of human diseases
利用细胞技术开发个体器官新型DDS及其在人类疾病治疗中的应用
  • 批准号:
    07558126
  • 财政年份:
    1995
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Joint Study on the Therapy of Diseases by Gene Transfer
基因转移治疗疾病的联合研究
  • 批准号:
    05044170
  • 财政年份:
    1993
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似国自然基金

能量代谢重编程通过组蛋白乳酸化修饰H4K16la介导NF-κB促进骨关节炎的机制研究
  • 批准号:
    32300652
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于ERS与TLR4/NF-κB信号通路交叉对话研究氯化两面针碱抗溃疡性结肠炎的作用机制
  • 批准号:
    82304828
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
艾叶活性成分Artemvulactone E靶向MAMDC2抑制STING/NF-κB通路抗疱疹病毒性脑炎的机制研究
  • 批准号:
    82373917
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
m6A识别蛋白YTHDC2通过星形胶质细胞LCN2调控IKK/NF-κB/TNFα轴在颞叶癫痫的作用及机制研究
  • 批准号:
    82371463
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
OXA1L基因变异调控活性氧介导的NF-κB信号通路导致线粒体肌病的机制研究
  • 批准号:
    82301006
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

癌随伴線維芽細胞におけるNFκBシグナル分子の役割
NFκB信号分子在副肿瘤成纤维细胞中的作用
  • 批准号:
    24K10345
  • 财政年份:
    2024
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis on the Antiviral Mechanism of an NF-kappa B Inhibitor against Severe Fever with Thrombocytopenia Syndrome Virus
NF-κB抑制剂对发热伴血小板减少综合征病毒的抗病毒机制分析
  • 批准号:
    23K15384
  • 财政年份:
    2023
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The non-canonical NF-kB pathway in regulatory T cells
调节性 T 细胞中的非经典 NF-kB 通路
  • 批准号:
    22K20868
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The landscape of NFκB transcription dynamics
NFκB 转录动力学景观
  • 批准号:
    10444634
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
The landscape of NFκB transcription dynamics
NFκB 转录动力学景观
  • 批准号:
    10686820
  • 财政年份:
    2022
  • 资助金额:
    $ 8.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了